Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany ...

The program is supported through Ferring’s Fertility Out Loud platform and is designed to support both male and female partners through their fertility journey.

Infertility isn’t an easy subject to talk about — and Ferring Pharmaceuticals knows it. Challenges related to family planning have been associated with social stigmatization, particularly for female ...

As the first FDA-approved fecal microbiota product, Rebyota represents a significant milestone, potentially clearing the way for other such treatments.

Ferring Pharmaceuticals presented the initial results from an ongoing Phase 3 trial (NCT05704244) in Japan assessing the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in ...

Ferring Pharmaceuticals A/S has struck a deal with Royalty Pharma for $500 million, capital it plans to plough into achieving a successful launch of its approved bladder cancer gene therapy, ...

Purvi Tailor, Ferring Pharmaceuticals' VP of HR, says focusing holistically on worker well-being is crucial for retaining top talent in healthcare.

Ferring activates first sites in a three-arm study of ADSTILADRIN as a monotherapy or in combination with chemotherapy or an immune checkpoint inhibitor in high-risk Bacillus Calmette-Guérin (BCG ...

Ferring Pharmaceuticals has suspended all shipments of its key fertility drug, Menopur. Insider obtained a memo Ferring Pharmaceuticals sent to healthcare providers.

Ferring Pharmaceuticals’ biotherapeutic passed an FDA committee vote for C. difficile despite some skepticism from a handful of members.

Human Microbiome-based Drugs and Diagnostics Global Markets Report 2025-2030 with Profiles of Leading Players - Ferring Pharmaceuticals, Nestle, BiomeBank, Genetic Analysis, and Vedanta ...